• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Health care technology in France.

作者信息

Weill C

机构信息

National School of Public Health, Saint-Maurice, France.

出版信息

Health Policy. 1994 Oct-Dec;30(1-3):123-62. doi: 10.1016/0168-8510(94)00686-9.

DOI:10.1016/0168-8510(94)00686-9
PMID:10139489
Abstract

The French health care system combines freedom of medical practice with nation-wide social security. The system is centrally regulated with specific attention to technology. Prices and budgets are also regulated. Despite these controls, concerns about quality of care began to appear in France in the 1970s. At the same time, increasing costs became an issue. Health care technology assessment has been under discussion as part of the solution to these problems since the early 1980s, but little was done until 1989, when a national agency was established to develop and coordinate health care technology assessment in France. In 1991, a new law on hospitalization strengthened the role of the government in health care and required extensive evaluation activities. The law has made legal requirements for the health care system and the government at all levels, as well as establishing specific institutions and public grants to support evaluation and related activities. While further evolution of the health care system is inevitable, it seems clear that technology assessment is becoming one of the key tools for addressing problems of quality of care and rising costs.

摘要

相似文献

1
Health care technology in France.
Health Policy. 1994 Oct-Dec;30(1-3):123-62. doi: 10.1016/0168-8510(94)00686-9.
2
Health technology assessment in France.法国的卫生技术评估
Int J Technol Assess Health Care. 2000 Spring;16(2):400-11. doi: 10.1017/s0266462300101060.
3
Health care technology in the Federal Republic of Germany.德意志联邦共和国的医疗保健技术。
Health Policy. 1994 Oct-Dec;30(1-3):163-205. doi: 10.1016/0168-8510(94)00687-a.
4
Health care technology in Australia.澳大利亚的医疗保健技术。
Health Policy. 1994 Oct-Dec;30(1-3):23-72. doi: 10.1016/0168-8510(94)00684-7.
5
Lessons from the eight countries.来自八个国家的经验教训。
Health Policy. 1994 Oct-Dec;30(1-3):397-421. doi: 10.1016/0168-8510(94)00691-7.
6
Health care technology in The Netherlands.荷兰的医疗保健技术。
Health Policy. 1994 Oct-Dec;30(1-3):207-55. doi: 10.1016/0168-8510(94)00688-b.
7
Health care technology in Canada (with special reference to Quebec).加拿大的医疗保健技术(特别提及魁北克省)。
Health Policy. 1994 Oct-Dec;30(1-3):73-122. doi: 10.1016/0168-8510(94)00685-8.
8
Managing medical technology: lessons for the United States from Quebec and France.管理医疗技术:魁北克和法国给美国的经验教训。
Int J Health Serv. 2000;30(3):617-39. doi: 10.2190/20H5-9N3J-1WC4-NXP7.
9
Health care technology as a policy issue.作为政策问题的医疗保健技术。
Health Policy. 1994 Oct-Dec;30(1-3):1-21. doi: 10.1016/0168-8510(94)00683-6.
10
Health care technology in Sweden.瑞典的医疗保健技术。
Health Policy. 1994 Oct-Dec;30(1-3):257-94. doi: 10.1016/0168-8510(94)00689-c.

引用本文的文献

1
Long-Term Trends and Projections of Multiple Myeloma Across Three Continents: A Comparative Study of China, the United States of America, the Russian Federation, England and France (1990-2036).三大洲多发性骨髓瘤的长期趋势与预测:中国、美利坚合众国、俄罗斯联邦、英国和法国的比较研究(1990 - 2036年)
Cancer Med. 2025 Jun;14(12):e70999. doi: 10.1002/cam4.70999.